Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of the new oncological drug durvalumab in Italian patients with stage III non-small cell lung cancer.
Buja, Alessandra; Pasello, Giulia; Schiavon, Marco; De Luca, Giuseppe; Rivera, Michele; Cozzolino, Claudia; De Polo, Anna; Scioni, Manuela; Bortolami, Alberto; Baldo, Vincenzo; Conte, PierFranco.
Afiliación
  • Buja A; Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, University of Padua, Padua, Italy.
  • Pasello G; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
  • Schiavon M; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • De Luca G; Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, University of Padua, Padua, Italy.
  • Rivera M; Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, University of Padua, Padua, Italy.
  • Cozzolino C; Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, University of Padua, Padua, Italy.
  • De Polo A; Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Scioni M; Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, University of Padua, Padua, Italy.
  • Bortolami A; Statistics Department, University of Padua, Padua, Italy.
  • Baldo V; Rete Oncologica Veneta (ROV), Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Conte P; Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, University of Padua, Padua, Italy.
Thorac Cancer ; 13(19): 2692-2698, 2022 10.
Article en En | MEDLINE | ID: mdl-35971638

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Revista: Thorac Cancer Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Singapur

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Revista: Thorac Cancer Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Singapur